Hamlet BioPharma AB publ

XSAT:HAMLET B (Sweden)   Ordinary Shares - Class B
kr 3.14 (-1.26%) Nov 28
At Loss
P/B:
9.21
Market Cap:
kr 526.78M ($ 48.33M)
Enterprise V:
kr 510.26M ($ 46.82M)
Volume:
79.15K
Avg Vol (2M):
145.06K
Warning! GuruFocus detected 1 Severe warning sign with HAMLET B. Try a 7-Day Free Trial to check it out.
Trade In:
Volume:
79.15K
Market Cap kr:
526.78M
Market Cap $:
48.33M
At Loss
Avg Vol (2M):
145.06K
Enterprise Value kr:
510.26M
Enterprise Value $:
46.82M
PB Ratio:
9.21
Alerts Website Sources Stock PDF
Dataset
Financial Download GuruFocus Premium Icon Manual of Stocksâ„¢

Business Description

Hamlet BioPharma AB publ

ISIN : SE0015661152
http://www.hamletpharma.com
Klinikgatan 32, BMC D10, Lund, SWE, SE-222 42

Share Class Description:

XSAT:HAMLET B: Ordinary Shares - Class B
Compare
Compare
OSTO:ABLIOSTO:STABLOSTO:BIOWKSOSTO:ACTIOSTO:ATORXOSTO:MAGLEOSTO:SPRINTOSTO:ACOUOSTO:ISOFOLOSTO:CLBIOOCSE:NOVO BVRTXREGNASX:CSLSGENXKRX:207940MRNAHKSE:02269XBRU:ARGXBNTX
Traded in other countries / regions
HAMLET B.Sweden7ZT.Germany
IPO Date
2015-10-23
Description
Hamlet BioPharma AB publ is a pharmaceutical company engaged in the research and development of drugs used for curing cancer.

Financial Strength

9/10
Name Current Vs Industry Vs History
Cash-To-Debt No Debt
Equity-to-Asset 0.92
Interest Coverage No Debt
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
3-Year EBITDA Growth Rate -40.3
3-Year EPS without NRI Growth Rate -49.8
3-Year FCF Growth Rate -57.8
3-Year Book Growth Rate 145.3

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 68.22
9-Day RSI 55.22
14-Day RSI 49.07
6-1 Month Momentum % -18.58
12-1 Month Momentum % 252.46

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 4.04
Quick Ratio 4.04
Cash Ratio 3.23

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -16.4

Profitability Rank

1/10
Name Current Vs Industry Vs History
ROE % -72.46
ROA % -65.65
ROIC % -93.22
ROC (Joel Greenblatt) % -7752.55
ROCE % -71.55

GF Value Rank

Name Current Vs Industry Vs History
PB Ratio 9.21
Price-to-Tangible-Book 19.63
EV-to-EBIT -11.56
EV-to-EBITDA -15.17
EV-to-FCF -14.52
Price-to-Net-Current-Asset-Value 34.89
Price-to-Net-Cash 44.86
Earnings Yield (Greenblatt) % -8.65
FCF Yield % -6.75

Financials (Next Earnings Date:2025-02-13)

XSAT:HAMLET B's 30-Y Financials
AAPL
Income Statement Breakdown FY
No Enough Data
AAPL
Balance Sheet Breakdown
No Enough Data
AAPL
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Hamlet BioPharma AB publ Executives

Details

GF Value

XSAT:HAMLET B

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil kr)
EPS (TTM) (kr) -0.273
Beta 0
Volatility % 149.17
14-Day RSI 49.07
14-Day ATR (kr) 0.300166
20-Day SMA (kr) 2.985
12-1 Month Momentum % 252.46
52-Week Range (kr) 1.0584 - 5.02
Shares Outstanding (Mil) 167.76

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Hamlet BioPharma AB publ Filings

Filing Date Document Date Form
No Filing Data

Hamlet BioPharma AB publ Stock Events

Financials Calendars
Event Date Price(kr)
No Event Data

Hamlet BioPharma AB publ Frequently Asked Questions

What is Hamlet BioPharma AB publ(XSAT:HAMLET B)'s stock price today?
The current price of XSAT:HAMLET B is kr3.14. The 52 week high of XSAT:HAMLET B is kr5.02 and 52 week low is kr1.06.
When is next earnings date of Hamlet BioPharma AB publ(XSAT:HAMLET B)?
The next earnings date of Hamlet BioPharma AB publ(XSAT:HAMLET B) is 2025-02-13.
Does Hamlet BioPharma AB publ(XSAT:HAMLET B) pay dividends? If so, how much?
Hamlet BioPharma AB publ(XSAT:HAMLET B) does not pay dividend.

Press Release

Subject Date
No Press Release
Research Tools
All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board
Product
Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文
Education
Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation
Company
About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program
Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey
Follow Us
download GuruFocus on Apple store download GuruFocus on Google Play
Disclaimers
GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.
© 2004-2024 GuruFocus.com, LLC. All Rights Reserved.